52 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
of the world's emerging experts on biomedical engineering and the employment of advanced materials and micro-technologies for cell and tissue culture … materials and properties designed as an innovative platform for adherent cell culture in small volumetric footprints with the potential to reduce media
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Oct 18
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
9:06am
and advanced materials to develop an innovative platform for larger scale adherent cell culture in small volumetric footprints.
The project will be led … of the world's emerging experts on biomedical engineering and the employment of advanced materials and micro-technologies for cell and tissue culture
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
this Notice of Meeting and accompanying materials through a broker, a financial institution, a participant, a trustee or administrator of a retirement savings … ), or a nominee of any of the foregoing that holds your securities on your behalf (an "Intermediary"), please complete and return the materials in accordance
6-K
EX-99.3
REPCF
Replicel Life Sciences Inc.
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
in such activities.
(o) "Marketing Materials" shall mean, in respect of a Distribution Product, all written, printed, video, audio and internet or web-based … materials, convention panels, speakers programs and other materials relating to the Distribution Product, other than Product Labels and Inserts, intended
D
REPCF
Replicel Life Sciences Inc.
4 Nov 19
$135.08K in equity, sold $135.08K, 1 investor
3:29pm
of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can … require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
6-K
eihytybvul7pp6x400d
15 Oct 09
Current report (foreign)
12:00am
6-K
EX-99.1
ollr611 gzqunv
17 Aug 23
Annual General and Special Meeting
11:22am
D
eya8f8qc13h
13 Sep 19
$76.03K in equity / securities to be acquired, sold $76.03K, 1 investor
12:40pm
6-K
7ek4u
17 May 12
Current report (foreign)
12:00am
6-K
uys8y 8g9sprn
26 Oct 11
Current report (foreign)
12:00am
6-K
EX-99.6
sfr 7kks5miv93
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
D
61jbe2dsfs5ty3
25 Apr 12
$594.05K in equity / options / securities to be acquired, sold $594.05K, 6 investors
12:00am
6-K
zcwg ezbc0m6
23 May 13
Current report (foreign)
12:00am
D
qpqjepszwd4u3rdgjwu
19 Apr 13
$70.21K in equity / options / securities to be acquired, sold $70.21K, 2 investors
12:00am
D
530f0fdv
4 Apr 12
$273K in equity / options / securities to be acquired, sold $273K, 6 investors
12:00am
D
rpq74ws9rqlup
26 Feb 21
$385.85K in equity, sold $385.85K, 1 investor
12:00am
D
a17f9r9ubqjyq4u
3 Jun 21
$111.57K in equity, sold $111.57K, 2 investors
5:03pm
D
4n05agsrazmtvb
22 Jan 19
$20.88K in equity, sold $20.88K, 1 investor
2:45pm
D
hdvue5dclsrzbl6vfc8
27 May 21
$9.01K in equity, sold $9.01K, 1 investor
12:22pm